PharmEvo (Private) Limited. – Trademark Portfolio

Entity Type: 99

PharmEvo (Private) Limited. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 2 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include EVOCHECK and PHARMEVO. The owner is based in Karachi.

P.E.C.H.S., Shahrah-e-Faisal

402, Business Avenue Block-6

Karachi 75400 , PK

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

EVOCHECK
EVOCHECK
Registered 2024
PHARMEVO
PHARMEVO
Registered 2024

Trademark Classifications

PharmEvo (Private) Limited.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (2 filings)

Surgical, medical, dental and veterinary apparatus and instruments

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does PharmEvo (Private) Limited. have?

PharmEvo (Private) Limited. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does PharmEvo (Private) Limited. file in?

PharmEvo (Private) Limited. files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are PharmEvo (Private) Limited.'s most well-known trademarks?

PharmEvo (Private) Limited.'s registered trademark portfolio includes well-known marks such as EVOCHECK and PHARMEVO. These are among 2 currently registered trademarks in the portfolio.

What is PharmEvo (Private) Limited.'s trademark registration success rate?

PharmEvo (Private) Limited. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.